Tandem Investment Advisors Inc. Has $889,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Tandem Investment Advisors Inc. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,521 shares of the healthcare conglomerate’s stock after acquiring an additional 21 shares during the quarter. Tandem Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $889,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in UNH. China Universal Asset Management Co. Ltd. boosted its position in shares of UnitedHealth Group by 20.6% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock valued at $5,376,000 after purchasing an additional 1,857 shares in the last quarter. Quent Capital LLC grew its stake in shares of UnitedHealth Group by 5.5% in the 1st quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock valued at $2,076,000 after buying an additional 217 shares during the period. Nelson Capital Management LLC raised its stake in UnitedHealth Group by 3.1% during the 1st quarter. Nelson Capital Management LLC now owns 12,844 shares of the healthcare conglomerate’s stock worth $6,354,000 after buying an additional 387 shares during the period. Allen Investment Management LLC increased its holdings in shares of UnitedHealth Group by 4.9% during the first quarter. Allen Investment Management LLC now owns 857,397 shares of the healthcare conglomerate’s stock valued at $424,154,000 after acquiring an additional 40,291 shares in the last quarter. Finally, Capital Wealth Planning LLC lifted its holdings in shares of UnitedHealth Group by 8.0% in the 1st quarter. Capital Wealth Planning LLC now owns 977,239 shares of the healthcare conglomerate’s stock worth $483,440,000 after purchasing an additional 72,068 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 1.5 %

UNH opened at $605.45 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The business has a 50 day simple moving average of $581.13 and a two-hundred day simple moving average of $543.74. The firm has a market capitalization of $557.18 billion, a price-to-earnings ratio of 39.44, a PEG ratio of 1.75 and a beta of 0.58. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.56 EPS. Analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.39%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on UNH shares. Truist Financial reaffirmed a “buy” rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 24th. Royal Bank of Canada lowered their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. TD Cowen boosted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Finally, Robert W. Baird lifted their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.